- Home
- NRBO vs ZOOZ Comparison
NRBO vs ZOOZ Comparison
Compare NRBO & ZOOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRBO
- ZOOZ
- Stock Information
- Founded
- NRBO N/A
- ZOOZ 2013
- Country
- NRBO United States
- ZOOZ Israel
- Employees
- NRBO N/A
- ZOOZ N/A
- Industry
- NRBO Biotechnology: Pharmaceutical Preparations
- ZOOZ
- Sector
- NRBO Health Care
- ZOOZ
- Exchange
- NRBO Nasdaq
- ZOOZ NYSE
- Market Cap
- NRBO 27.9M
- ZOOZ 24.5M
- IPO Year
- NRBO N/A
- ZOOZ N/A
- Fundamental
- Price
- NRBO $2.42
- ZOOZ $2.77
- Analyst Decision
- NRBO Strong Buy
- ZOOZ Strong Buy
- Analyst Count
- NRBO 1
- ZOOZ 1
- Target Price
- NRBO $10.00
- ZOOZ $5.00
- AVG Volume (30 Days)
- NRBO 36.9K
- ZOOZ 15.6K
- Earning Date
- NRBO 11-07-2024
- ZOOZ 12-03-2024
- Dividend Yield
- NRBO N/A
- ZOOZ N/A
- EPS Growth
- NRBO N/A
- ZOOZ N/A
- EPS
- NRBO N/A
- ZOOZ N/A
- Revenue
- NRBO N/A
- ZOOZ $506,656.00
- Revenue This Year
- NRBO N/A
- ZOOZ N/A
- Revenue Next Year
- NRBO N/A
- ZOOZ $37.50
- P/E Ratio
- NRBO N/A
- ZOOZ N/A
- Revenue Growth
- NRBO N/A
- ZOOZ N/A
- 52 Week Low
- NRBO $2.08
- ZOOZ $1.66
- 52 Week High
- NRBO $6.75
- ZOOZ $4.60
- Technical
- Relative Strength Index (RSI)
- NRBO 40.83
- ZOOZ N/A
- Support Level
- NRBO $2.30
- ZOOZ N/A
- Resistance Level
- NRBO $2.50
- ZOOZ N/A
- Average True Range (ATR)
- NRBO 0.23
- ZOOZ 0.00
- MACD
- NRBO -0.01
- ZOOZ 0.00
- Stochastic Oscillator
- NRBO 24.75
- ZOOZ 0.00
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency, and greater flexibility.